Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
08/27/2003 | EP1338591A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2- carboxylic acid and esters thereof, and use in the synthesis of perindopril |
08/27/2003 | EP1338588A1 Method of resolving optical isomers of amino acid derivative |
08/27/2003 | EP1338336A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts |
08/27/2003 | EP1337590A1 Efficient cyclic-bridged cyanine dyes |
08/27/2003 | EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
08/27/2003 | EP1189902B1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist |
08/27/2003 | EP0988057B1 Bioreductive conjugates for drug targeting |
08/27/2003 | EP0901469B1 Arylalkylpiperazine compounds as antioxidants |
08/27/2003 | EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
08/27/2003 | EP0862552B1 Succinimide and maleimide cytokine inhibitors |
08/27/2003 | CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity |
08/27/2003 | CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors |
08/27/2003 | CN1438993A Ethylenediamine derivatives |
08/27/2003 | CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
08/27/2003 | CN1438639A Otical recording material |
08/27/2003 | CN1119329C Method of purifying carbazole ester precursors of 6-chloro-alpha-methy-carbazole-2-acetic acid |
08/27/2003 | CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists |
08/26/2003 | US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride |
08/26/2003 | US6610731 Antiinflammatory |
08/26/2003 | US6610729 Hydroxamic acid derivatives and medicinal utilization thereof |
08/26/2003 | US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof |
08/26/2003 | US6610689 Viricides |
08/23/2003 | CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
08/21/2003 | WO2003069411A1 Visible radiation sensitive composition |
08/21/2003 | WO2003069350A2 Small molecule modulators of apoptosis |
08/21/2003 | WO2003068837A1 Indole resins, epoxy resins and resin compositions containing the same |
08/21/2003 | WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents |
08/21/2003 | WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders |
08/21/2003 | WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor |
08/21/2003 | WO2003068741A1 Indole derivatives substituted with long-chain alcohols and medicaments containing them |
08/21/2003 | WO2003068740A1 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
08/21/2003 | WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
08/21/2003 | WO2003068242A1 Phospholipids as caspase inhibitor prodrugs |
08/21/2003 | WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders |
08/21/2003 | WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases |
08/21/2003 | WO2003068157A2 Kinase inhibitors and methods of use thereof |
08/21/2003 | WO2002100847A3 Factor xa inhibitor |
08/21/2003 | WO2002020463A3 Fxr modulators |
08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
08/21/2003 | US20030158417 Indole type compound derivatives for use as antiinflammation or antiproliferative agents, treating cardiovascular disorders, Alzheimer's disease |
08/21/2003 | US20030158405 N-benzhydryl indole compounds |
08/21/2003 | US20030158256 (Arylaminoaceamido)acetonitrile derivatives |
08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
08/21/2003 | US20030158246 For the treatment of prostaglandin mediated diseases, such as allergic asthma or rhinitis. |
08/21/2003 | US20030158231 Sulfonamide compounds as protease inhibitors |
08/21/2003 | US20030158225 Novel compounds |
08/21/2003 | US20030158222 2-3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (an-tipsychotic agents) |
08/21/2003 | US20030158216 2-acyl indole derivatives and their use as antitumor agents |
08/21/2003 | US20030158215 Tyrosine kinase inhibitors |
08/21/2003 | US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders |
08/21/2003 | US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
08/21/2003 | US20030158198 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
08/21/2003 | US20030158188 An antagonists for treating pain, inflammations, urinary incontinence and bladder overactivity |
08/21/2003 | US20030158177 Treating or preventing obesity |
08/21/2003 | US20030158155 Mmp-12 inhibitors |
08/21/2003 | US20030158152 Protease inhibitors and their pharmaceutical uses |
08/21/2003 | US20030158127 Aromatic sulfenates for type I phototherapy |
08/21/2003 | US20030158121 Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same |
08/21/2003 | US20030155299 Caprolactam from aminocapronitrile; extraction, distillation |
08/21/2003 | CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases |
08/21/2003 | CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents |
08/21/2003 | CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
08/20/2003 | EP1336604A1 Sulfoximine derivatives as MMP-inhibitors or antibiotics |
08/20/2003 | EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
08/20/2003 | EP1335920A2 Small molecule compositions for binding to hsp90 |
08/20/2003 | EP1335901A1 Pharmaceutically active sulfanilide derivatives |
08/20/2003 | EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
08/20/2003 | EP1335895A2 Protease inhibitors and their pharmaceutical uses |
08/20/2003 | EP1335722A2 Compounds useful in the treatment of cns disorders |
08/20/2003 | EP1335720A1 Sulphonamides for the treatment of central nervous system diseases |
08/20/2003 | EP1263504B1 Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina |
08/20/2003 | EP1173519B1 Novel carbopyronine fluorescence dyes |
08/20/2003 | EP1150944B1 N2-phenylamidine derivatives |
08/20/2003 | EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands |
08/20/2003 | EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives |
08/20/2003 | CN1437598A Novel indole derivatives |
08/20/2003 | CN1437597A Substituted phenyl-Piperazine derivatives, their preparation and use |
08/20/2003 | CN1437596A Phenylpiperazinyl derivatives |
08/20/2003 | CN1437581A Glucagon antagonists/inverse agonists |
08/20/2003 | CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent |
08/20/2003 | CN1118451C Acylated derivatives of melatonin and its analogues as medicine |
08/19/2003 | US6608715 Wavelength converter using Bragg-grating |
08/19/2003 | US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
08/19/2003 | US6608100 HIV protease inhibitors based on amino acid derivatives |
08/19/2003 | US6608099 Indole sPLA2 inhibitors |
08/19/2003 | US6608084 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion |
08/19/2003 | US6608070 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens |
08/19/2003 | US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
08/14/2003 | WO2003067332A2 Sulfonate derivatives and the use therof as latent acids |
08/14/2003 | WO2003066889A2 Assay for acytyltransferase or deacetylase activity |
08/14/2003 | WO2003066628A1 Oxadiazoles having antiproliferative activity |
08/14/2003 | WO2003066597A2 Guanidino compounds |
08/14/2003 | WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
08/14/2003 | WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions |
08/14/2003 | WO2003066570A1 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands |
08/14/2003 | WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
08/14/2003 | WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
08/14/2003 | US20030153770 Novel sPLA2 inhibitors |
08/14/2003 | US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders |
08/14/2003 | US20030153754 Gamma-aminobutyric acid (gaba); anxiolytic agents, treating sleep and seizure disorders |